Stock screener

GALT

Conviction 44HealthcareScan · Mon, Aug 10, 2026
GALT$3.10-10.14%
ResistanceSupportVol 14Insider sell
63 bars
2
3
Vol MA14 425.56K
May 11May 28Jun 16Jul 6Jul 23Aug 10
GALECTIN THERAPEUTICS INCPHARMACEUTICAL PREPARATIONSwww.galectintherapeutics.com ↗
Price3.10
Change-10.14%
Gap-3.77%
Rel volume1.46×
Avg volume511.56K
Avg $ vol1.99M
SMA 203.61
SMA 503.49
SMA 2003.60
Price vs 50-11.09%
Price vs 200-13.78%
MA stackbearish
50/200 cross—
Supertrenddown · 4.04
RSI (14)42
MACD hist-0.06
MACD cross—
Stoch %K / %D33 / 38
ADX (14)20
+DI / −DI23 / 26
RSI divergence—
MACD divergence—
ATR %+11.33%
ADR %9.57%
52w high6.51
52w low2.08
From 52w high-52.38%
Above 52w low+49.04%
New 52w highNo
SqueezeOff
Bollinger width67.41%
%B0.29
Donchian pos13.43%
Donchian high5.55
Donchian low2.72
AVWAP (52w high)3.55
vs AVWAP high-12.56%
AVWAP (52w low)3.75
vs AVWAP low-17.32%
OBV trendFlat
Chaikin MF (20)-0.19
Today vs 20d1.46×
Avg vol (14d)425.56K
Avg vol (20d)511.56K
Avg $ vol (20d)1.99M
Market cap204.16M
RS 3m (vs SPY)+57.81%
RS 6m (vs SPY)+7.79%
RS line new highNo
Trend template2/8
Technical rank33.7
1 week+2.31%
1 month-23.65%
3 months+47.62%
6 months+10.71%
1 year-19.27%
YTD-23.46%
P/E-6.62
P/B-1.55
P/S—
P/FCF-8.55
EPS-0.4800
Div yield—
ROE23.37%
ROA-195.67%
Debt/Eq—
Current2.15
EV/EBITDA-9.46
Gross margin—
Net margin—
Rev growth—
EPS growth34.46%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value190.05M
Revenue—
Net income-5.05M
Gross profit—
Free cash flow-23.88M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out65.86M
Employees9
ListedWed, Sep 4, 2002
Free float43.66M
Float %66.3%
Short interest8.49M
Days to cover11.3d
Short volume63.2%
Squeeze score86 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction44 / 100
Pattern quality—
Tech rank33.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.37
Support2.61
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Broke out
    Jun 1
    1 scan
  2. Setting up
    Jul 14
    1 scan

Congress activity

Disclosed STOCK Act trades in GALT

All disclosures →
No recent disclosed trades by Congress in GALT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GALT · 4 buys · 6 sells

InsiderSideShares
Jamil Khurram
Chief Medical Officer · Stock option (right to buy) · 2026-07-14
Exercise16.25K
Jamil Khurram
Chief Medical Officer · Common Stock · 2026-07-14
Exercise16.25K
Jamil Khurram
Chief Medical Officer · Common Stock · 2026-07-14
Sell16.25K
Shlevin Harold H.
Director · Common Stock · 2026-06-29
Exercise22.27K
Shlevin Harold H.
Director · Common Stock · 2026-06-29
Sell22.27K
Jamil Khurram
Chief Medical Officer · Common Stock · 2026-06-29
Sell47.47K
Shlevin Harold H.
Director · Stock Option (right to buy) · 2026-06-29
Exercise22.27K
Jamil Khurram
Chief Medical Officer · Stock Option (right to buy) · 2026-06-29
Exercise47.47K
Jamil Khurram
Chief Medical Officer · Common Stock · 2026-06-29
Exercise47.47K
Shlevin Harold H.
Director · Common Stock · 2026-06-26
Exercise7.73K

SEC filings

EDGAR filings in GALT · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.